← FDA DRUG APPROVALS

FDA ANDA · ANDA088194

THIORIDAZINE HYDROCHLORIDE

Sponsor: ANI PHARMS

APPLICATION
ANDA088194
TYPE
ANDA
ORIGINAL APPROVAL
1983-04-14
LATEST ACTION
1986-11-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

THIORIDAZINE HYDROCHLORIDEDiscontinued
THIORIDAZINE HYDROCHLORIDE 50MG · TABLET · ORAL

Approval history

1986-11-07Manufacturing (CMC) · Supplement 17AP
1986-11-07Manufacturing (CMC) · Supplement 15AP
1986-11-07Manufacturing (CMC) · Supplement 16AP
1984-06-29Manufacturing (CMC) · Supplement 1AP
1984-01-17Manufacturing (CMC) · Supplement 4AP
1984-01-17Manufacturing (CMC) · Supplement 5AP
1984-01-17Manufacturing (CMC) · Supplement 3AP
1983-11-07Manufacturing (CMC) · Supplement 2AP
1983-04-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →